Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Stock Buy: AT&T vs. C3.ai


AT (NYSE: T) and C3.ai (NYSE: AI) generally appeal to different types of tech investors. AT, one of the largest telecom companies in America, is usually owned for stability and dividends instead of aggressive gains. C3.ai, an enterprise AI software company that went public less than three years ago, is a speculative growth play.

Yet both of these stocks disappointed those target investors. If you had invested $1,000 in AT on April 11, 2022 -- the first day it traded separately from Warner Bros. Discovery -- your investment would only be worth about $760 today. If you had invested $1,000 in C3.ai's IPO on Dec 9, 2020, your investment would be worth less than $600. Let's see why these two stocks flopped, and if either one is still worth buying in this challenging market.

Image source: Getty Images.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Stock

€0.056
-0.890%
Allergy Therapeutics PLC shows a slight decrease today, losing -€0.001 (-0.890%) compared to yesterday.

Like: 0
T
Share

Comments